• buy rosetta stone korean buy true image home 2010 buying windows xp 32 bit where to buy rosetta stone in australia buy windows 7 ultimate activation key cheapest adobe indesign buy after effects cs4 mac buy streets & trips 2010 buy adobe photoshop elements 6.0 mac buy techtool 5 buy fireworks cs3 cheap buy windows 7 student price canada microsoft office 2007 price compare buy adobe illustrator 6 cheap autocad 2009
  • cheap aperture frame buy autocad for mac uk buying photoshop elements 6 best price rosetta stone spanish latin buy microsoft office powerpoint online cheap nero 7 premium best price dragon naturally speaking professional price of windows server 2003 license adobe cs5 design premium cheap cheap microsoft office 2007 professional upgrade buy camtasia 6 best price quicken starter edition 2010 filemaker pro 11 student discount purchase adobe acrobat 6 cheapest 2007 publisher

    Incidence and clearance of oral human papillomavirus infection in men: the HIM cohort study

    Fri, Nov 8, 2013

    Oral Cancer News

    Source: The Lancet
    Published: September 7, 2013
    By: Aimée R Kreimer PhD, Christine M Pierce Campbell PhD, Hui-Yi Lin PhD, William Fulp MS, Mary R Papenfuss MS, Martha Abrahamsen MPH, Prof Allan Hildesheim PhD, Prof Luisa L Villa PhD, Jorge J Salmerón MD, Prof Eduardo Lazcano-Ponce PhD, Prof Anna R Giuliano PhD
     

    Summary

    Background

    Oral human papillomavirus (HPV) infection causes a subset of oropharyngeal cancers. These cancers disproportionately affect men, are increasing in incidence, and have no proven prevention methods. We aimed to establish the natural history of oral HPV infection in men.

    Methods

    To estimate incidence and clearance of HPV infections, men residing in Brazil, Mexico, and the USA who were HIV negative and reported no history of anogenital cancer were recruited into the HPV Infection in Men (HIM) cohort study. A subset of the cohort who provided two or more oral rinse-and-gargle samples with valid HPV results and who completed a minimum of 2 weeks of follow-up were included in this analysis. Oral rinse-and-gargle samples and questionnaire data were obtained every 6 months for up to 4 years. Samples were analysed for the presence of oncogenic and non-oncogenic HPV infections by the linear array method.

    Findings

    1626 men aged 18—73 years and with a median follow-up of 12·7 months (IQR 12·1—14·7) were included in the analysis. During the first 12 months of follow-up, 4·4% (95% CI 3·5—5·6; n=115 incident infections) of men acquired an incident oral HPV infection, 1·7% (1·2—2·5; n=53 incident infections) an oral oncogenic HPV infection, and 0·6% (0·3—1·1; n=18 incident infections) an oral HPV 16 infection. Acquisition of oral oncogenic HPV was significantly associated with smoking and not being married or cohabiting, but was similar across countries, age groups, and reported sexual behaviours. Median duration of infection was 6·9 months (95 % CI 6·2—9·3; n=45 cleared infections) for any HPV, 6·3 months (6·0—9·9; n=18 cleared infections) for oncogenic HPV, and 7·3 months (6·0—not estimable; n=5 cleared infections) for HPV 16. Eight of the 18 incident oral HPV 16 infections persisted for two or more study visits.

    Interpretation

    Newly acquired oral oncogenic HPV infections in healthy men were rare and most were cleared within 1 year. Additional studies into the natural history of HPV are needed to inform development of infection-related prevention efforts.

    Funding

    US National Cancer Institute, Merck Sharp & Dohme.

    * This news story was resourced by the Oral Cancer Foundation, and vetted for appropriateness and accuracy.

     

    Print Friendly
    Be Sociable, Share!
    , , ,

    Leave a Reply

    You must be logged in to post a comment.